Humana beats Q2, raises FY25 adj. EPS & revenue outlook despite GAAP cut

$HUM (+1,32 %)

• Q2 GAAP EPS: $4.51 | Adj. EPS: $6.27

• YTD GAAP EPS: $14.81 | Adj. EPS: $17.85

• Insurance Benefit Ratio: 89.9% (in line)

• FY25 Adj. EPS Guide: ↑ to ~$17.00 (from ~$16.25)

• FY25 GAAP EPS Guide: ↓ to ~$13.77 (from ~$14.68)

• FY25 Revenue Guide: ↑ to ≥ $128B (from $126–128B)

• Medicare Advantage membership decline revised to ~500K (from ~550K)

• CenterWell patient growth outlook raised to 50K–70K (from 30K–50K)